Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment.
Saved in:
| Title: | Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment. |
|---|---|
| Authors: | Dacic S; Department of Pathology University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: sanja.dacic@yale.edu., Cao X; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson, Houston, Texas., Bota-Rabassedas N; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson, Houston, Texas., Sanchez-Espiridion B; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson, Houston, Texas., Berezowska S; Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Han Y; Department of Pathology, Shanghai Chest Hospital, Shanghai, People's Republic of China., Chung JH; Department of Pathology and Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea., Beasley MB; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York., Dongmei L; Department of Pathology, Beijing Cancer Center, Beijing, People's Republic of China., Hwang D; Sunnybrook Health Sciences Centre, Odette Cancer Centre, Ontario, Canada., Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Minami Y; Department of Pathology, National Hospital Organization Ibarakihigashi National Hospital, The Center of Chest Diseases and Severe Motor & Intellectual Disabilities, Tokai, Ibaraki, Japan., Papotti M; Department of Pathology, University of Turin, Torino, Italy., Rekhtman N; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Roden AC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Thunnissen E; Department of Pathology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Tsao MS; Department of Pathology, University Health Network and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Yoshida A; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Wang L; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson, Houston, Texas., Hartman DJ; Department of Pathology University of Pittsburgh, Pittsburgh, Pennsylvania., Jerome JA; Department of Pathology University of Pittsburgh, Pittsburgh, Pennsylvania., Kadara H; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson, Houston, Texas., Chou TY; Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan., Wistuba II; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson, Houston, Texas. |
| Corporate Authors: | IASLC Pathology Committee |
| Source: | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Feb; Vol. 19 (2), pp. 273-284. Date of Electronic Publication: 2023 Sep 16. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
